BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9186920)

  • 1. ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes.
    Plump AS; Azrolan N; Odaka H; Wu L; Jiang X; Tall A; Eisenberg S; Breslow JL
    J Lipid Res; 1997 May; 38(5):1033-47. PubMed ID: 9186920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster.
    Woollett LA; Kearney DM; Spady DK
    J Lipid Res; 1997 Nov; 38(11):2289-302. PubMed ID: 9392427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
    Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
    J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse.
    Spady DK; Woollett LA; Meidell RS; Hobbs HH
    J Lipid Res; 1998 Jul; 39(7):1483-92. PubMed ID: 9684752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of scavenger receptor class B type I-mediated selective cholesteryl ester uptake from apoA-I(-/-) high density lipoprotein (HDL) by apolipoprotein A-I requires HDL reorganization by lecithin cholesterol acyltransferase.
    Temel RE; Parks JS; Williams DL
    J Biol Chem; 2003 Feb; 278(7):4792-9. PubMed ID: 12473673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
    Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
    Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.
    Rached F; Santos RD; Camont L; Miname MH; Lhomme M; Dauteuille C; Lecocq S; Serrano CV; Chapman MJ; Kontush A
    J Lipid Res; 2014 Dec; 55(12):2509-20. PubMed ID: 25341944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL; Jiang XC; Tall AR
    J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
    Francone OL; Royer L; Haghpassand M
    J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
    Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
    J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control.
    Wang N; Weng W; Breslow JL; Tall AR
    J Biol Chem; 1996 Aug; 271(35):21001-4. PubMed ID: 8798380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.